Search
Close this search box.

Clinical Trials Day 2024: The Trailblazers Among Us

Share article:

Facebook
WhatsApp
Twitter
LinkedIn
Clinical Trials Day MAC Clinical Research

Join us on 20th May to celebrate Clinical Trials Day! A day when the clinical research industry comes together to reflect and recognise all that has been accomplished thanks to clinical trials and the people behind them.

Clinical Trials Day 2024 Logo

Trailblazers Among Us

This year the theme is The Trailblazers Among Us, in celebration of modern-day trailblazers: clinical research professionals. They are the people who push the advancement of human health, and their dedication is what makes medical breakthroughs possible.

We are proud to be part of this industry with many of our own clinical research trailblazers. Innovation has been key to MAC from the very beginning having established one of the UK’s first-ever memory clinics in 1988.

Our memory clinics have helped many people get the support they need, including diagnosis of Alzheimer’s disease and dementia. They have also been key in supporting our research, providing invaluable access to patients and volunteers for dementia, which we have conducted many clinical studies in. We are committed to continuing this research to help improve the lives of patients and their families living with such a debilitating disease.

Our Memory Assessment Research Clinics are still at the heart of MAC today and something we continue to offer as a free service in our community.

Our clinical research professionals: pioneers in research

At MAC, our team of experts lead the way in many aspects of clinical research, including the implementation of our unique scientific techniques and assessments to help ensure the efficacy of drugs early in development as well as provide first-class training in overcoming the placebo response.

We have also gained expertise in conducting psychedelic studies, which has garnered attention in recent years for their potential to treat an array of mental health conditions. We are proud to be the first clinical research company to not only administer high doses of psychedelics but also the first to dose Ibogaine in a clinical environment in the UK, along with the first to dose 50mg of Psilocybin as well as Deuterated DMT (IV/IM). Our bespoke facilities include psychedelic treatment rooms and a state-of-the-art sleep laboratory, for ensuring the optimum environment for both psychedelic and sleep studies.

It is important to recognise that behind every breakthrough and every milestone, there are the people who make it possible – the participants and clinical research employees – whose passion and commitment drive progress. As we look to the future, let’s continue to celebrate and support these trailblazers, for they are the pioneers of change.

Make sure to check our social media during the week of Clinical Trials Day for inspiring stories, patient testimonials, and highlights of our groundbreaking research!

If you would like more information on how we can support you, contact us here.

Find us on:

LinkedIn: www.linkedin.com/company/mac-clinical-research

Facebook: www.facebook.com/MACClinicalResearchCRO

Instagram: www.instagram.com/mac_clinicalresearchcro

Share article:

Facebook
WhatsApp
Twitter
LinkedIn